News | Artificial Intelligence | August 07, 2017

Xavier University Announces Healthcare Artificial Intelligence Summit

New Xavier Center for Artificial Intelligence will host event to accelerate adoption of AI in healthcare

Xavier University Announces Healthcare Artificial Intelligence Summit

August 7, 2017 — Xavier University has launched the Xavier Center for Artificial Intelligence (AI), a pioneering effort to accelerate the use of artificial intelligence to improve healthcare. The Center’s first major initiative will be the AI Summit on Aug. 24-25 on Xavier’s campus in Cincinnati. Xavier will lead representatives from the medical device and pharmaceutical industries and the U.S. Food and Drug Administration to further develop artificial intelligence to promote and protect patient health.

In addition to learning from each other, attendees will form working teams tasked with developing plans that apply AI to solve their quality, regulatory and supply chain challenges. They will continue to meet in the months after the summit and present their solutions at the 2018 AI Summit. Solutions from the summit will be available for free for any company or organization across the globe to implement.

Representatives from the FDA, Johnson & Johnson, AstraZeneca, Eli Lilly & Co., Abbott, Dell and IBM Watson Health will be among the speakers.

“We’re bringing together the major global players in artificial intelligence to focus on technology that could transform the healthcare industry,” said Marla Phillips, director of Xavier Health, which runs the Center for AI. “We believe the implementation of AI in the healthcare field is needed now more than ever.”

The Center for AI is a collaborative effort involving all three of Xavier’s colleges — Arts & Sciences, Professional Sciences and the Williams College of Business — presenting new academic opportunities for students across the campus.

AI could be used to improve patient safety, reduce drug costs, and avoid product and drug recalls, in addition to the advances being made in healthcare diagnostics, including the early detection of conditions such as dementia and depression.

AI Summit speakers will share how AI already is advancing healthcare, providing hope that AI will advance the diagnosis and treatment of complex conditions by putting powerful information in the hands of physicians. Participants also will learn how computers can be used to scan unstructured data to identify trends and patterns that humans are unable to detect. That can minimize failures in drug and product safety, moving organizations from reactive to predictive mindsets.

FDA officials will share the agency’s strategic priorities involving AI implementation to increase product quality and patient safety.

“Some people think that artificial intelligence is still just a concept, that its practical application is still years away,” Phillips said. “But it’s been used for years in many applications and has tremendous potential to make a difference in the pharmaceutical and medical device industries.”

Watch the VIDEO "Expanding Role for Artificial Intelligence in Medical Imaging."

For more information: www.xavierai.com

Related Content

Anatomage Releases Anatomage Cloud Platform
News | Remote Viewing Systems | July 16, 2019
Anatomage Inc. released an update to the Anatomage Cloud platform that allows medical and dental professionals to...
Graphic courtesy Pixabay

Graphic courtesy Pixabay

Feature | Artificial Intelligence | July 15, 2019 | By Greg Freiherr
Siemens has long focused on automation as a way to make diagnostic equipment faster and more efficient.
Videos | Artificial Intelligence | July 12, 2019
Khan Siddiqui, M.D., founder and CEO of HOPPR, discusses the economic advantages and costs presented by...
Videos | Digital Pathology | July 11, 2019
Toby Cornish, M.D., Ph.D., associate professor and medical director of informatics at the University of Colorado Scho
FDA Clears Koios DS Breast 2.0 AI-based Software
News | Ultrasound Women's Health | July 11, 2019
Koios Medical announced its second 510(k) clearance from the U.S. Food and Drug Administration (FDA).
SimonMed Imaging Implements ProFound AI for 3-D Tomosynthesis
News | Mammography | July 10, 2019
Arizona-based SimonMed Imaging announced their implementation of the first U.S. Food and Drug Administration (FDA)-...
Researchers Use Artificial Intelligence to Deliver Personalized Radiation Therapy
News | Radiation Therapy | July 09, 2019
New Cleveland Clinic-led research shows that artificial intelligence (AI) can use medical scans and health records to...
Videos | Enterprise Imaging | July 09, 2019
ITN Associate Editor Jeff Zagoudis speaks with Don Dennison
Videos | Enterprise Imaging | July 08, 2019
ITN Associate Editor Jeff Zagoudis speaks with Don Dennison